Kura Oncology Inc (NAS:KURA)
$ 20.06 -0.52 (-2.53%) Market Cap: 1.53 Bil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 3.03 GF Score: 36/100

Kura Oncology Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 09:10PM GMT
Release Date Price: $29.49 (-6.97%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Thanks so much. Good afternoon, everybody. Welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the Biotech Equity Research Analysts at Barclays. And thank you, everyone, for taking time out of their day, of course. And if you have questions, you can always ping me, institutional investors can e-mail me at [email protected] or ping me on Bloomberg. Because we got great pleasure to introduce the management team from Kura, or at least the CEO, Troy Wilson. Thank you so much for spending time with us this afternoon.

Questions & Answers

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

And just as an opening question, I just ask all my companies this -- about your -- the core competency of the company and the kind of -- I guess, the differentiation at the core of Kura.

Troy Edward Wilson
Kura Oncology, Inc. - Chairman, CEO & President

Sure, Peter. So first of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot